83 related articles for article (PubMed ID: 17550056)
1. Novel thrombopoietic agents: preliminary activity, potential benefit.
Bussel JB
J Support Oncol; 2007 Apr; 5(4 Suppl 2):63-84. PubMed ID: 17550056
[No Abstract] [Full Text] [Related]
2. FDA approves thrombopoiesis-stimulating agent.
Thompson CA
Am J Health Syst Pharm; 2008 Oct; 65(19):1788. PubMed ID: 18796411
[No Abstract] [Full Text] [Related]
3. Thrombopoiesis: new ITP paradigm?
Despotovic JM; Ware RE
Blood; 2011 Jul; 118(1):1-2. PubMed ID: 21737604
[No Abstract] [Full Text] [Related]
4. Platelet production bolstered with romiplostim approval.
Morrow T
Manag Care; 2008 Oct; 17(10):49-50. PubMed ID: 18990926
[No Abstract] [Full Text] [Related]
5. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura.
Nurden AT; Viallard JF; Nurden P
Lancet; 2009 May; 373(9674):1562-9. PubMed ID: 19324405
[TBL] [Abstract][Full Text] [Related]
6. Immune thrombocytopenic purpura--the changing therapeutic landscape.
Bromberg ME
N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
[No Abstract] [Full Text] [Related]
7. Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?
Sallmon H; Gutti RK; Ferrer-Marin F; Liu ZJ; Sola-Visner MC
J Perinatol; 2010 Dec; 30(12):765-9. PubMed ID: 20410910
[TBL] [Abstract][Full Text] [Related]
8. AMG 531: an investigational thrombopoiesis-stimulating peptibody.
Nichol JL
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):723-5. PubMed ID: 16933266
[TBL] [Abstract][Full Text] [Related]
9. The use of second-generation thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Levy B; Arnason JE; Bussel JB
Curr Opin Oncol; 2008 Nov; 20(6):690-6. PubMed ID: 18841052
[TBL] [Abstract][Full Text] [Related]
10. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
Kuter DJ
Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
[TBL] [Abstract][Full Text] [Related]
11. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S26-32. PubMed ID: 19245931
[TBL] [Abstract][Full Text] [Related]
12. Overview of thrombopoietic agents in the treatment of thrombocytopenia.
Kobos R; Bussel JB
Clin Lymphoma Myeloma; 2008 Feb; 8(1):33-43. PubMed ID: 18501086
[TBL] [Abstract][Full Text] [Related]
13. Salvage therapy of autoimmune thrombocytopenic purpura revealing non-Hodgkin lymphoma by the thrombopoietin receptor agonist romiplostim.
Al-Nawakil C; Park S; Chapuis N; Dreyfus F; Szwebel TA; Gibault L; Molina T; Hermine O; Bouscary D; Tamburini J
Br J Haematol; 2012 Jan; 156(1):145-7. PubMed ID: 21848881
[No Abstract] [Full Text] [Related]
14. [New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists].
Khellaf M
Rev Med Interne; 2009 Oct; 30(9 Suppl):13-5. PubMed ID: 19874983
[No Abstract] [Full Text] [Related]
15. Romiplostim: a novel thrombopoiesis-stimulating agent.
Perreault S; Burzynski J
Am J Health Syst Pharm; 2009 May; 66(9):817-24. PubMed ID: 19386944
[TBL] [Abstract][Full Text] [Related]
16. ITP, interrupted.
Stasi R
Blood; 2011 Oct; 118(16):4297-8. PubMed ID: 22021448
[No Abstract] [Full Text] [Related]
17. The road to romiplostim approval and beyond.
Lyman GH
Oncology (Williston Park); 2009 Jul; 23(8):709-10, 715. PubMed ID: 19711586
[No Abstract] [Full Text] [Related]
18. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
19. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
Newland A; Caulier MT; Kappers-Klunne M; Schipperus MR; Lefrere F; Zwaginga JJ; Christal J; Chen CF; Nichol JL
Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981
[TBL] [Abstract][Full Text] [Related]
20. New insights and therapeutics for immune-mediated thrombocytopenia.
Metjian A; Abrams CS
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):71-84. PubMed ID: 18095908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
